LLY

900.36

-0.41%↓

UNH

599.42

+1.06%↑

NVO

129.6

-1.65%↓

JNJ

167.6

+0.43%↑

ABBV

198.27

+0.95%↑

LLY

900.36

-0.41%↓

UNH

599.42

+1.06%↑

NVO

129.6

-1.65%↓

JNJ

167.6

+0.43%↑

ABBV

198.27

+0.95%↑

LLY

900.36

-0.41%↓

UNH

599.42

+1.06%↑

NVO

129.6

-1.65%↓

JNJ

167.6

+0.43%↑

ABBV

198.27

+0.95%↑

LLY

900.36

-0.41%↓

UNH

599.42

+1.06%↑

NVO

129.6

-1.65%↓

JNJ

167.6

+0.43%↑

ABBV

198.27

+0.95%↑

LLY

900.36

-0.41%↓

UNH

599.42

+1.06%↑

NVO

129.6

-1.65%↓

JNJ

167.6

+0.43%↑

ABBV

198.27

+0.95%↑

Search

AstraZeneca PLC ADR

Abierto

80.96 0.22

Resumen

Variación precio

24h

Actual

Mínimo

79.95

Máximo

81.29

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+9.82 upside

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

AstraZeneca PLC ADR Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

25 jul 2024, 09:17 UTC

Ganancias

AstraZeneca Raises Guidance After Results Beat Market Expectations -- Update

25 jul 2024, 06:48 UTC

Ganancias

AstraZeneca Raises Guidance After Revenue, Earnings Beat Market Expectations

9 sept 2024, 07:56 UTC

Charlas de Mercado

Big Pharma's Stability in Return on R&D Investment Is Encouraging -- Market Talk

5 sept 2024, 13:00 UTC

Principales Noticias

China Detains AstraZeneca Employees Over Alleged Transport of Unapproved Drug -- WSJ

29 jul 2024, 10:30 UTC

Principales Noticias

Big Pharma Rallies and Moves Past Obesity -- Heard on the Street -- WSJ

25 jul 2024, 13:20 UTC

Ganancias

AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD

25 jul 2024, 09:21 UTC

Charlas de Mercado
Ganancias

AstraZeneca's Guidance Lift Is Conservative; Risks to Upside -- Market Talk

25 jul 2024, 07:05 UTC

Charlas de Mercado
Ganancias

AstraZeneca Guidance Raise Signals Portfolio Potential -- Market Talk

25 jul 2024, 06:06 UTC

Ganancias

AstraZeneca Increased Interim Dividend by 7c to $1.00

25 jul 2024, 06:04 UTC

Ganancias

AstraZeneca Had Seen Core EPS Grow by Low Double-Digit to Low Teens Percentage Range

25 jul 2024, 06:04 UTC

Ganancias

AstraZeneca Had Seen Total Revenue Grow by Low Double-Digit to Low Teens Percentage Range

25 jul 2024, 06:04 UTC

Ganancias

AstraZeneca Sees Core EPS Growth in 2024 by Mid Teens Percentage Range At Constant Currency

25 jul 2024, 06:04 UTC

Ganancias

AstraZeneca Sees Total Revenue Growth in 2024 by Mid Teens Percentage Range At Constant Currency

25 jul 2024, 06:03 UTC

Ganancias

AstraZeneca Raises 2024 View

25 jul 2024, 06:02 UTC

Ganancias

AstraZeneca 2Q Revenue Consensus Was $12.7B

25 jul 2024, 06:02 UTC

Ganancias

AstraZeneca 2Q Core EPS Consensus Was $1.95

25 jul 2024, 06:00 UTC

Ganancias

AstraZeneca PLC 2Q Adj EPS $1.98

25 jul 2024, 06:00 UTC

Ganancias

AstraZeneca PLC 2Q Pretax Pft $2.4B

25 jul 2024, 06:00 UTC

Ganancias

AstraZeneca PLC 2Q Rev $12.94B

25 jul 2024, 06:00 UTC

Ganancias

AstraZeneca PLC 2Q Oper Pft $2.75B

25 jul 2024, 06:00 UTC

Ganancias

AstraZeneca PLC 2Q Net Pft $1.93B

25 jul 2024, 06:00 UTC

Ganancias

AstraZeneca PLC 2Q EPS $1.24

15 jul 2024, 06:04 UTC

Adquisiciones, fusiones, absorciones

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

15 jul 2024, 06:04 UTC

Adquisiciones, fusiones, absorciones

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

15 jul 2024, 06:02 UTC

Adquisiciones, fusiones, absorciones

AstraZeneca: Acquisition Includes $800M Upfront at Deal Closing

15 jul 2024, 06:02 UTC

Adquisiciones, fusiones, absorciones

AstraZeneca: Amolyt Pharma's Total Consideration of Up to $1.05B

15 jul 2024, 06:01 UTC

Adquisiciones, fusiones, absorciones

AstraZeneca: Acquisition Bolsters Alexion Rare Disease Late-Stage Pipeline

15 jul 2024, 06:00 UTC

Adquisiciones, fusiones, absorciones

AstraZeneca Completes Acquisition of Amolyt Pharma

15 jul 2024, 06:00 UTC

Adquisiciones, fusiones, absorciones

AstraZeneca PLC Acquisition of Amolyt Pharma completed

15 jul 2024, 06:00 UTC

Adquisiciones, fusiones, absorciones

AstraZeneca PLC Acquisition of Amolyt Pharma completed

Comparación entre iguales

Cambio de precio

AstraZeneca PLC ADR Esperado

Precio Objetivo

By TipRanks

9.82% repunte

Estimación a 12 meses

Media 88.83 USD  9.82%

Máximo 99 USD

Mínimo 74 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para AstraZeneca PLC ADR Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

7 ratings

6

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

N/A / 87.21Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

No Evidence